domingo, 10 de noviembre de 2024

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

https://www.nature.com/articles/s41467-024-51848-y?utm_campaign=+62969471&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=

No hay comentarios:

Publicar un comentario